One of the canonical features of AD pathology is the accumulation of amyloid β (Aβ) plaque as a result of changes in the pathways responsible for Aβ; namely, the pathways regulated by the amyloid precursor protein (APP) and β secretase-1 (BACE1) [99]. This evidence concerns the gene APP and Alzheimer disease.